Medicine–food homology bioactives in Parkinson’s disease: multi-target oxidative-stress modulation and translation to dietary supplements
MFH compounds are promising, hypothesis-generating candidates for adjunctive nutrition in PD, pending clinical dose-response and long-term safety validation. No clinical efficacy has been established.
Authors
- Jia-Jia Sang (ORCID: https://orcid.org/0000-0003-1257-2498)
- Sijia Ma (ORCID: https://orcid.org/0000-0001-9775-0294)
- Qiong Wu (ORCID: https://orcid.org/0000-0003-2244-4350)
- Meng Wang (ORCID: https://orcid.org/0000-0002-1573-0255)
- Ying Zhang (ORCID: https://orcid.org/0000-0001-6355-9205)
- Chao Wang (ORCID: https://orcid.org/0000-0003-4812-6000)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Jiangsu Provincial Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2025-11-21
- DOI
- https://doi.org/10.3389/fnut.2025.1677749
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Academy of Chinese Medical Sciences